IL79570A0 - Oxa-and azahomocyclostatine polypeptides and related intermediates - Google Patents

Oxa-and azahomocyclostatine polypeptides and related intermediates

Info

Publication number
IL79570A0
IL79570A0 IL79570A IL7957086A IL79570A0 IL 79570 A0 IL79570 A0 IL 79570A0 IL 79570 A IL79570 A IL 79570A IL 7957086 A IL7957086 A IL 7957086A IL 79570 A0 IL79570 A0 IL 79570A0
Authority
IL
Israel
Prior art keywords
azahomocyclostatine
oxa
polypeptides
related intermediates
intermediates
Prior art date
Application number
IL79570A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/762,099 external-priority patent/US4668769A/en
Application filed by Pfizer filed Critical Pfizer
Publication of IL79570A0 publication Critical patent/IL79570A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL79570A 1985-08-02 1986-07-30 Oxa-and azahomocyclostatine polypeptides and related intermediates IL79570A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/762,099 US4668769A (en) 1985-08-02 1985-08-02 Oxa- and azahomocyclostatine polypeptides
US06/780,353 US4599198A (en) 1985-08-02 1985-09-26 Intermediates in polypeptide synthesis

Publications (1)

Publication Number Publication Date
IL79570A0 true IL79570A0 (en) 1986-10-31

Family

ID=27117072

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79570A IL79570A0 (en) 1985-08-02 1986-07-30 Oxa-and azahomocyclostatine polypeptides and related intermediates

Country Status (14)

Country Link
US (1) US4599198A (da)
EP (1) EP0211580A3 (da)
KR (1) KR890003602B1 (da)
AU (3) AU569821B2 (da)
CA (1) CA1305175C (da)
DK (1) DK366686A (da)
ES (1) ES2001056A6 (da)
FI (1) FI863153A (da)
GR (1) GR862009B (da)
HU (1) HU204284B (da)
IE (1) IE862072L (da)
IL (1) IL79570A0 (da)
NZ (2) NZ217067A (da)
PT (1) PT83123B (da)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
US5214129A (en) * 1985-01-23 1993-05-25 Abbott Laboratories Peptidylaminodiols
HU200473B (en) * 1985-11-01 1990-06-28 Pfizer Process for producing polypeptides containing difluorocyclostatine and pharmaceutical compositions comprising same
CA1282549C (en) * 1985-11-12 1991-04-02 Eric M. Gordon Aminocarbonyl renin inhibitors
US4757050A (en) * 1985-12-23 1988-07-12 E. R. Squibb Sons, Inc. Ureido renin inhibitors
CA1297631C (en) * 1985-12-23 1992-03-17 Sesha I. Natarajan Ureido renin inhibitors
IL81234A (en) * 1986-01-16 1992-09-06 Abbott Lab Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
US4885292A (en) * 1986-02-03 1989-12-05 E. R. Squibb & Sons, Inc. N-heterocyclic alcohol renin inhibitors
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
DE3635907A1 (de) * 1986-10-22 1988-04-28 Merck Patent Gmbh Hydroxy-aminosaeurederivate
US4931429A (en) * 1987-10-01 1990-06-05 G. D. Searle & Co. α-aminoacyl β-aminoacyl aminodiols as anti-hypertensive agents
US4965372A (en) * 1989-01-19 1990-10-23 Pfizer Inc. Process and intermediates for isopropyl 3S-amino-2R-hydroxy-alkanoates
US5036155A (en) * 1989-06-29 1991-07-30 Pfizer Inc. Process for isopropyl 3S-amino-2R-hydroxy-alkanoates
US5166400A (en) * 1989-01-19 1992-11-24 Pfizer Inc. Intermediates for isopropyl 3S-amino-2R-hydroxy-alkanoates
EP0472077A3 (en) * 1990-08-24 1993-03-31 Bayer Ag Phosphonate containing hydroxyethylamin- and norstatin-type pseudopeptides
US5475027A (en) * 1990-11-19 1995-12-12 G.D. Searle & Co. Retroviral protease inhibitors
US5583238A (en) * 1990-11-19 1996-12-10 G. D. Searle & Co. Method for making intermediates useful in synthesis of retroviral protease inhibitors
US5475013A (en) * 1990-11-19 1995-12-12 Monsanto Company Retroviral protease inhibitors
US5510487A (en) * 1990-11-19 1996-04-23 G.D. Searle & Co. Retroviral protease inhibitors
US5614522A (en) * 1990-11-19 1997-03-25 G.D. Searle & Co. Retroviral protease inhibitors
CA2096528C (en) 1990-11-19 2005-12-06 Kathryn Lea Reed Retroviral protease inhibitors
US5648511A (en) * 1990-11-19 1997-07-15 G.D. Searle & Co. Method for making intermediates useful in the synthesis of retroviral protease inhibitors
CA2096407C (en) * 1990-11-19 2007-10-02 Kathryn Lea Reed Retroviral protease inhibitors
US5482947A (en) * 1990-11-19 1996-01-09 Talley; John J. Retroviral protease inhibitors
JPH0572071A (ja) * 1991-04-15 1993-03-23 Toshiba Corp 圧力測定装置
CA2136312A1 (en) * 1992-05-21 1993-11-25 Michael Clare Retroviral protease inhibitors
US6022994A (en) 1992-08-25 2000-02-08 G. D. Searle &. Co. Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5760076A (en) * 1992-08-25 1998-06-02 G.D Searle & Co. Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DE69311810T2 (de) * 1992-08-25 1997-11-27 Monsanto Co N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren
US7141609B2 (en) 1992-08-25 2006-11-28 G.D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
ES2123065T3 (es) 1992-08-25 1999-01-01 Searle & Co Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
US6046190A (en) * 1992-08-25 2000-04-04 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
EP0656888B1 (en) * 1992-08-25 1998-01-07 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5968942A (en) 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US6743929B1 (en) * 1992-08-25 2004-06-01 G. D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5830897A (en) * 1992-08-27 1998-11-03 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5578606A (en) 1992-10-30 1996-11-26 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
US6156768A (en) 1992-10-30 2000-12-05 G. D. Searle & Co. Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
US5756498A (en) * 1992-10-30 1998-05-26 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
US6337398B1 (en) 1992-10-30 2002-01-08 G.D. Searle & Co. Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
WO1994010136A1 (en) * 1992-10-30 1994-05-11 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
US5514801A (en) * 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
US5830888A (en) * 1993-04-16 1998-11-03 Monsanto Company Macrocyclic retroviral protease inhibitors
US5750648A (en) * 1993-08-20 1998-05-12 G.D. Searle & Co. Retroviral protease inhibitors and combinations thereof
US5602119A (en) * 1993-10-29 1997-02-11 Vazquez; Michael L. Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
CN1055681C (zh) * 1994-11-04 2000-08-23 参天制药株式会社 带有羟基的新1,3－二烷基脲衍生物
CA2210889C (en) * 1995-01-20 2007-08-28 G.D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
US5831117A (en) * 1995-01-20 1998-11-03 G. D. Searle & Co. Method of preparing retroviral protease inhibitor intermediates
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6140505A (en) * 1995-03-10 2000-10-31 G. D. Searle & Co. Synthesis of benzo fused heterocyclic sulfonyl chlorides
US6407134B1 (en) * 1995-03-10 2002-06-18 G. D. Searle & Co. Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5985870A (en) * 1995-03-10 1999-11-16 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6169085B1 (en) 1995-03-10 2001-01-02 G. D. Searle & Company Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
EP1188766A1 (en) 1995-03-10 2002-03-20 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6667307B2 (en) * 1997-12-19 2003-12-23 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5776971A (en) 1995-03-10 1998-07-07 G.D. Searle & Co. Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US7339078B2 (en) * 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
CN1149223C (zh) * 1995-03-10 2004-05-12 G·D·瑟尔公司 杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
ES2158997T3 (es) * 1995-10-04 2001-09-16 Ajinomoto Kk Esteres alfa-aciloxi-beta-aminotiolcarboxilicos y metodo e intermedios para su produccion.
CA2236236A1 (en) * 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
HUP9901872A3 (en) * 1996-02-08 2001-06-28 Nippon Kayaku Kk Process for producing optically active cyanohydrins
WO1997046514A1 (en) * 1996-05-31 1997-12-11 Novartis Ag Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues
US6711297B1 (en) * 1998-07-03 2004-03-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and apparatus for dynamic transfer of image data
US6538006B1 (en) 1998-07-08 2003-03-25 Pharmacia Corporation Retroviral protease inhibitors
US6696488B2 (en) 2000-08-11 2004-02-24 The Brigham And Women's Hospital, Inc. (Hydroxyethyl)ureas as inhibitors of alzheimer's β-amyloid production
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0318463D0 (en) * 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318464D0 (en) * 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) * 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
GB0319690D0 (en) * 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
US20050064076A1 (en) * 2003-09-22 2005-03-24 Fmc Technologies, Inc. Method of measuring volatile components of foods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1108180A (en) * 1976-07-21 1981-09-01 Hamao Umezawa Analogs of bestatin
US4479941A (en) * 1981-12-10 1984-10-30 Merck & Co., Inc. Renin inhibitory peptides having PHE13 delection
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
AU573735B2 (en) * 1983-02-07 1988-06-23 Aktiebolaget Hassle Peptide analogue enzyme inhibitors
IL74272A (en) * 1984-02-16 1991-06-10 Poudres & Explosifs Ste Nale Preparation of carbamic acid derivatives
DK34086A (da) * 1985-01-23 1986-07-24 Abbott Lab Peptidylaminodioler
CA1286846C (en) * 1985-02-12 1991-07-23 Catherine Cazaubon Peptide derivatives which inhibit renin and acid proteases
HU200473B (en) * 1985-11-01 1990-06-28 Pfizer Process for producing polypeptides containing difluorocyclostatine and pharmaceutical compositions comprising same
CA1297631C (en) * 1985-12-23 1992-03-17 Sesha I. Natarajan Ureido renin inhibitors

Also Published As

Publication number Publication date
NZ217067A (en) 1990-08-28
KR870002161A (ko) 1987-03-30
AU633629B2 (en) 1993-02-04
AU598913B2 (en) 1990-07-05
AU569821B2 (en) 1988-02-18
IE862072L (en) 1987-02-02
DK366686A (da) 1987-03-20
CA1305175C (en) 1992-07-14
GR862009B (en) 1986-12-23
ES2001056A6 (es) 1988-04-16
PT83123B (pt) 1989-03-30
FI863153A (fi) 1987-02-03
HUT41815A (en) 1987-05-28
KR890003602B1 (ko) 1989-09-27
US4599198A (en) 1986-07-08
NZ228380A (en) 1990-08-28
AU6079086A (en) 1987-05-14
DK366686D0 (da) 1986-08-01
AU1239288A (en) 1988-06-02
FI863153A0 (fi) 1986-08-01
AU6385090A (en) 1991-01-10
EP0211580A3 (en) 1989-08-09
HU204284B (en) 1991-12-30
EP0211580A2 (en) 1987-02-25
PT83123A (en) 1986-09-01

Similar Documents

Publication Publication Date Title
IL79570A0 (en) Oxa-and azahomocyclostatine polypeptides and related intermediates
ZA865738B (en) Oxa-and azahomocyclostatine polypeptides and related intermediates
IL84270A0 (en) Nor-statine and nor-cyclostatine polypeptides
ZA867748B (en) Novel polypeptides
GB2164044B (en) -hanp related polypeptides and their use
GB8605654D0 (en) Wrist support
ZA868305B (en) Difluorocyclostatine containing polypeptides
EP0216080A3 (en) Novel plasmids and transformants
GB8500007D0 (en) Proteins
GB8605402D0 (en) Umbrella
ZA878158B (en) Nor-statine and nor-cyclostatine polypeptides
IE851433L (en) Pentapeptides and related intermediates
IE851223L (en) Isoxazolidines and related intermediates
IE850337L (en) Benzothiazolopyrimidinones and intermediates thereof
IE851068L (en) Dibenzoxepins and intermediates thereof
GB2179476B (en) Analog clock
IE852750L (en) Oxa - and thia- diazoles
GB8502605D0 (en) Polypeptides
IE852797L (en) Polypeptides
IE860118L (en) Pyrrolobenzimidazoles and intermediates thereof
GB8626622D0 (en) Polypeptides
GB8509405D0 (en) Ceramic material
IE882268L (en) Thiadiazoles and related intermediates
IE862508L (en) Heterobicycloalkanes and intermediates
IE881298L (en) Pyrrolophenylalkanolamines and intermediates

Legal Events

Date Code Title Description
RH Patent void